Aimwell Partners Inc (AIMN)

$0.00 +0.00 (7.69%)
Market Cap 429,000.00
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,877,900
Avg Vol 2,349,506
Day's Range N/A - N/A
Shares Out 330.14M
Stochastic %K 23%
Beta 1,466.80
Analysts Strong Buy
Price Target N/A

Company Profile

Lee Pharmaceuticals, Inc. provides personal care products in the United States. The company offers aloe vera products, antacids, cosmetics and douches, cough and cold products, depilatories and waxes, laxatives, lip balm products, men's personal care products, monticello drugs, oral care products, pain relievers, skin care products, tobacco accessories, topical ointments and creams, baby care products, and vitamins and nutritional products, as well as nasal sprays, lip conditioners, and over the...

Industry: Shell Companies
Sector: Financial Services
Phone: 307-278-1360
Address:
11 N Water Street, Mobile, United States
Ramseydog
Ramseydog Aug. 19 at 1:41 AM
🚀 $NICH is quietly building something bigger than another supplement brand — NutraVeri is becoming the infrastructure layer for the entire category. In ~60 seconds founders get a free, deterministic NutraVeri Score across 6 dimensions (formula strength, ingredient evidence, claim risk, dose, label readiness, market fit) built on actual FDA/FTC warning letters and public data. No black-box AI, no account required. Recent moves: expanding into full commercialization (warehousing, fulfillment, distribution), active JV talks with a major U.S. cGMP facility, and now opening the Label Readiness Engine to retired NFL players who want to own their own products instead of just endorsing someone else’s. From concept → scored → manufactured → customer doorstep. That’s the play in a tightening regulatory environment. Watch this one. 💪 $CRDL $AIMN $VNRX $DNA #NICH #NutraVeri #Supplements #Wellness #cGMP #Biotech https://grok.com/share/bGVnYWN5_c2efe96f-46dc-4d5e-8fa7-a3e5d32a1679
0 · Reply
Ramseydog
Ramseydog Aug. 17 at 1:58 PM
🚨 $AIMN AimwellBio just secured a patented Behavioral AI portfolio backed by work involving Oxford Science and a Sanofi pilot. This could be a major step in bringing AI-driven behavioral insights into real-world healthcare applications. 🧠🤖 Patented IP + AI + pharmaceutical validation = a setup worth watching closely. $AIMN $AI $BIOTECH $TECH #AIMN #AI #Biotech #BehavioralAI #Healthcare
0 · Reply
URocka
URocka Aug. 11 at 2:03 PM
$AIMN there is a lot of press releases but mostly fluff and no meat...
0 · Reply
mp161
mp161 Aug. 10 at 2:28 PM
$AIMN what will produce revenue?!
1 · Reply
FastFreddy69
FastFreddy69 Aug. 4 at 5:32 PM
$AIMN scam run now
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 5:42 PM
$AIMN The chart cloud columbous -
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 5:34 PM
oh - $AIMN Technology Collaboration Under Evaluation Separately, AimwellBio confirmed that it is actively evaluating potential technology collaboration opportunities with Dr. Jones spanning behavioral engagement and adherence intelligence capabilities that would complement the platform's existing validation architecture.
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 5:33 PM
$AIMN The chart - Perfect Range level for turtle shell - Accumulation Dad.
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 12:39 PM
$AIMN Looking for attention! Loading. Timing is the end of July, Marky notes
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 12:35 PM
$AIMN - Focus on the chart
0 · Reply
Latest News on AIMN
No data available.
Ramseydog
Ramseydog Aug. 19 at 1:41 AM
🚀 $NICH is quietly building something bigger than another supplement brand — NutraVeri is becoming the infrastructure layer for the entire category. In ~60 seconds founders get a free, deterministic NutraVeri Score across 6 dimensions (formula strength, ingredient evidence, claim risk, dose, label readiness, market fit) built on actual FDA/FTC warning letters and public data. No black-box AI, no account required. Recent moves: expanding into full commercialization (warehousing, fulfillment, distribution), active JV talks with a major U.S. cGMP facility, and now opening the Label Readiness Engine to retired NFL players who want to own their own products instead of just endorsing someone else’s. From concept → scored → manufactured → customer doorstep. That’s the play in a tightening regulatory environment. Watch this one. 💪 $CRDL $AIMN $VNRX $DNA #NICH #NutraVeri #Supplements #Wellness #cGMP #Biotech https://grok.com/share/bGVnYWN5_c2efe96f-46dc-4d5e-8fa7-a3e5d32a1679
0 · Reply
Ramseydog
Ramseydog Aug. 17 at 1:58 PM
🚨 $AIMN AimwellBio just secured a patented Behavioral AI portfolio backed by work involving Oxford Science and a Sanofi pilot. This could be a major step in bringing AI-driven behavioral insights into real-world healthcare applications. 🧠🤖 Patented IP + AI + pharmaceutical validation = a setup worth watching closely. $AIMN $AI $BIOTECH $TECH #AIMN #AI #Biotech #BehavioralAI #Healthcare
0 · Reply
URocka
URocka Aug. 11 at 2:03 PM
$AIMN there is a lot of press releases but mostly fluff and no meat...
0 · Reply
mp161
mp161 Aug. 10 at 2:28 PM
$AIMN what will produce revenue?!
1 · Reply
FastFreddy69
FastFreddy69 Aug. 4 at 5:32 PM
$AIMN scam run now
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 5:42 PM
$AIMN The chart cloud columbous -
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 5:34 PM
oh - $AIMN Technology Collaboration Under Evaluation Separately, AimwellBio confirmed that it is actively evaluating potential technology collaboration opportunities with Dr. Jones spanning behavioral engagement and adherence intelligence capabilities that would complement the platform's existing validation architecture.
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 5:33 PM
$AIMN The chart - Perfect Range level for turtle shell - Accumulation Dad.
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 12:39 PM
$AIMN Looking for attention! Loading. Timing is the end of July, Marky notes
0 · Reply
MikeTechnician
MikeTechnician Jul. 31 at 12:35 PM
$AIMN - Focus on the chart
0 · Reply
MikeTechnician
MikeTechnician Jul. 30 at 12:51 PM
$AIMN 1 Minute Indicators Summary BUY average @tradingview https://www.tradingview.com/symbols/OTC-AIMN/technicals/
0 · Reply
MikeTechnician
MikeTechnician Jul. 30 at 12:22 PM
$AIMN Chart, On accumulation dip is a gift !?
0 · Reply
URocka
URocka Jul. 29 at 12:01 PM
$AIMN When will we get to Rock? It's been a long time.....
0 · Reply
MikeTechnician
MikeTechnician Jul. 28 at 6:48 PM
$AIMN - $NICH loading
0 · Reply
MikeTechnician
MikeTechnician Jul. 28 at 11:26 AM
$AIMN News : AimwellBio (AIMN) is building the Federated Health Intelligence Network - and preparing to introduce the physicians, scientists and healthcare experts whose knowledge deserves greater visibility. https://www.stocktitan.net/news/AIMN/the-world-s-most-valuable-healthcare-database-may-already-exist-the-2zlkuz3do9kj.html
0 · Reply
URocka
URocka Jul. 27 at 1:53 PM
$AIMN Well no Volume trading at the moment... wonder WHY????? REAL Business or hype and fluff??? Nobody knows... $PVSP $CYBL damn otc
0 · Reply
PrnceMichael
PrnceMichael Jul. 27 at 12:49 PM
$AIMN The Professionals Arrived First - Now Their Institutions are Following: Aimwell Partners Inc. Confirms Enterprise Interest Driven by Its Credentialed Observer Network @AimwellBIO @AimwellPartners https://www.accessnewswire.com/newsroom/en/business-and-professional-services/the-professionals-arrived-first-now-their-institutions-are-follo-1188053
0 · Reply
URocka
URocka Jul. 26 at 6:48 AM
$AIMN how do you feel about this new business created out of thin air by the RONN people? Curious where they got credibility for this kind of work....it definitely wasn't part of the scam before with hydro business lies....
0 · Reply
Stockprofiler
Stockprofiler Jul. 24 at 4:38 PM
$AIMN Aimwell Partners Inc. (OTC: AIMN) announced that effective immediately its Observer-tier access to the AimwellBio decision intelligence platform is available at no cost to credentialed biopharma professionals, including physicians, clinical researchers, and regulatory specialists. Verified credentials are the only requirement. @AimwellBIO @AimwellPartners https://www.stocktitan.net/news/AIMN/aimwell-partners-inc-otc-aimn-opens-no-cost-observer-access-and-z7ak16hmntnj.html
0 · Reply
UltimateTrader_22
UltimateTrader_22 Jul. 24 at 11:53 AM
$AIMN Effective immediately, Observer-tier access to the AimwellBio platform is available at no cost to credentialed biopharma professionals https://stockhouse.com/news/press-releases/2026/07/22/aimwell-partners-inc-otc-aimn-opens-no-cost-observer-access-and-publishes-the @AimwellBIO @AimwellPartners @OTCMarkets
0 · Reply
St0ckman691
St0ckman691 Jul. 24 at 11:44 AM
$AIMN starting to build a new uptrend here as selling seems to have ceased.
0 · Reply
UltimateTrader_22
UltimateTrader_22 Jul. 23 at 7:16 PM
$AIMN @AimwellPartners entered the $100B+ RegTech market with the launch of AimwellBio. As healthcare becomes the fastest-growing vertical in regulatory tech, Aimwell is building the "trust layer" for AI in medicine. 🔹 Solving the 47% AI error rate in medical advice. 🔹 Targeting $140B in annual BioPharma intelligence spend. 🔹 Launching the Federated Health Intelligence Network (FHIN). Check out the full release: https://accessnewswire.com/newsroom/en/business-and-professional-services/aimwellbio-launches-the-system-that-catches-what-ai-gets-wrong-b-1157560 #Investing #StockMarket #OTC #AI #BioPharma $AIMN #AimwellBio
0 · Reply